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a b s t r a c t
Stroke is the most common cause of motor disabilities and is a major cause of mortality worldwide. Adult
stem cells have been shown to be effective against neuronal degeneration through mechanisms that
include both the recovery of neurotransmitter activity and a decrease in apoptosis and oxidative stress.
We chose the lineage stroke-prone spontaneously hypertensive rat (SHRSP) as a model for stem cell
therapy. SHRSP rats can develop such severe hypertension that they generally suffer a stroke at
approximately 1 year of age. The aim of this study was to evaluate whether mesenchymal stem cells
(MSCs) decrease apoptotic death and oxidative stress in existing SHRSP brain tissue. The results of qRT-
PCR assays showed higher levels of the antiapoptotic Bcl-2 gene in the MSC-treated animals, compared
with untreated. Our study also showed that superoxide, apoptotic cells, and by-products of lipid
peroxidation decreased in MSC-treated SHRSP to levels similar those found in the animal controls, Wistar
Kyoto rats. In addition, we saw a repair of morphological damage at the hippocampal region after MSC
transplantation. These data suggest that MSCs have neuroprotective and antioxidant potential in stroke-
prone spontaneously hypertensive rats.
& 2014 The Authors. Published by Elsevier Inc.
Bone marrow-derived stem cell administration constitutes one
of the promising new strategies in the treatment of neural damage
caused by hypertension and stroke. Several studies have described
the beneﬁcial effects of treatment with bone marrow-derived
mesenchymal stem cells (MSCs) in animal models of ischemic
stroke [1,2]. Furthermore, the feasibility and safety of a therapy for
stroke using autologous MSCs in humans has already been
examined in a pilot clinical study [3,4]. MSCs are found in speciﬁc
locations in the body, where they remain quiescent and undiffer-
entiated. When severe damage occurs, cellular signaling molecules
control the chemotaxis of these cells to the affected regions, where
the MSCs will replace cells or tissue [5,6].
Recent studies suggest that repair of the nervous system
requires certain combinations of therapies to restore the loss of
cells, based on the already established neural network in addition
to the blood supply and intrinsic mechanisms of repair. Many
studies have demonstrated that MSCs can give rise to neural cells,
both in vitro and in vivo [7–11]. After an ischemic event, bone
marrow stem cells may be involved in reparative processes. There
is increasing evidence that bone marrow MSCs may be an alter-
native to new forms of therapy [12].
Many studies using adult mesenchymal stem cells have been tested
for several disease models [13–15]. It is a consensus that transplanta-
tion of MSCs, such as those derived from bone marrow, can promote
tissue repair not only by the stimulation of proliferation, migration,
and differentiation of endogenous progenitors found in several tissues,
but also via factors that enhance tissue repair and regeneration, as well
as by decreasing inﬂammatory and immune reactions and apoptosis
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[16–19]. The oxidative stress theory of aging [20] is one of the most
widely accepted models of mechanisms involved in cellular senes-
cence. It predicts that free radicals, especially reactive oxygen species
(ROS), may cause damage and mutations to cellular components such
as DNA strand breaks [21] and lipid peroxidation [19,22]. It is known
that ROS are involved in apoptotic processes by activating/deactivating
many enzymes including the respectively pro- and antiapoptotic B-cell
leukemia 2-associated X (Bax) and B-cell leukemia 2 (Bcl-2) [23,24].
The expression of Bcl-2 protein reduces the oxidation reactions in cells.
Bcl-2 is an antiapoptotic protein and marker. This protein protects the
mitochondria from apoptosis by reducing the concentration of free
Ca2þ in the lumen of the endoplasmic reticulum (ER), promoting a
lower transfer of these ions from the ER to the mitochondria. Thus, the
protein Bcl-2 can inhibit mitochondrial dysfunction in the apoptotic
process, protecting cells in the process of “programmed death” [25]. In
contrast, Bax protein is known as the most important proapoptotic
protein and, similar to other members of the Bcl-2 family, Bax may
promote cell death by apoptosis. In systems that overexpress Bax
protein, its presence in the mitochondria causes inhibition of the
respiratory chain. This inhibition results in a massive release of
mitochondrial calcium and an ultimate release of cytochrome c from
the intermembrane space and into cytosol, culminating in the activa-
tion of caspases and cell death by apoptosis [26]. Thus, Bcl-2 protein
can inhibit mitochondrial dysfunction, whereas Bax protein is known
as the most important proapoptotic protein and may lead to cell
death [27].
Stroke-prone spontaneously hypertensive (SHRSP) rats are
considered a good animal model of human essential or primary
hypertension. This model has been extensively used to study
cardiovascular and neurological diseases. As in humans, the
hypertensive response starts with advancing age in this strain of
rats, and the cause of the increasing blood pressure remains
unknown. Increased blood pressure begins at approximately 5–6
weeks of age, and the systolic pressure may reach values between
190 and 230 mm Hg in adults. Starting between 40 and 50 weeks,
SHRSP rats develop characteristics of cardiovascular disease, such
as hypertrophy of the heart and hyperplasia of the blood vessels.
Several of these animals may develop still higher blood pressure
and die of stroke [28–31].
These animals can develop such severe hypertension that they
generally suffer a stroke at approximately 1 year of age. This stroke
has also been associated with elevated oxidative stress and
neuronal apoptosis [32–35]. Based on this feature, we chose SHRSP
rats as an animal model for brain damage.
The local transplantation of bone marrow stromal cells in
therapeutic applications permits the efﬁcient reconstruction of
many defects caused by neurodegenerative diseases. A number of
preclinical studies in animal models have convincingly shown the
feasibility of marrow stromal cell grafts for several purposes, even
though extensive work will still be required to optimize the
procedures, even in their simplest applications [36,37].
To better understand the effects of MSCs transplanted into the
brain on decreasing apoptosis and oxidative stress occurrence we
have used the SHRSP model and transplanted bone marrow-
derived MSCs into the cisterna magna. We also evaluated the
viability of these cells from this stroke model. Our data suggest
that mesenchymal stem cells have a neuroprotective and antiox-
idant potential in stroke-prone spontaneously hypertensive rats.
Material and methods
Chemicals
All antibodies were obtained from Molecular Probes (part of
Life Technologies, Carlsbad, CA, USA). Culture media and culture
ﬂasks were obtained from Gibco (Life Technologies). All other
chemicals and culture consumables were obtained from Sigma–
Aldrich Corp. (St. Louis, MO, USA). Chemicals for PCR were
obtained from Promega (Madison, WI, USA), Invitrogen (Life
Technologies), and Applied Biosystems (Life Technologies).
Animals
Male Wistar Kyoto (WKY) and SHRSP rats (12, 24, and 48 weeks
of age) were purchased from the Center for Development of
Experimental Models for Biology (Universidade Federal de São
Paulo (UNIFESP), São Paulo, Brazil). All animals were housed under
standard pathogen-free conditions (light/dark cycle 12/12 h, con-
stant room temperature at 2272 1C, food and water ad libitum).
All of the experimental procedures were conducted according to
international regulations and were approved by the internal Ethics
Committee on Animal Research of UNIFESP/EPM (Approval No.
1060/11). The animals were sorted into three age groups (12
weeks, considered young; 24 weeks, considered adult; and 48
weeks, considered old). For MSC transplantation procedure, old
SHRSP rats (48 weeks of age) were randomly divided into three
groups as follows: group I, CTR, control untreated (n ¼ 10); group
II, phosphate-buffered saline (PBS), injected with vehicle only,
used as sham-operated animals (n ¼ 10); group III, MSC, animals
treated with mesenchymal stem cells (n ¼ 30).
Blood pressure measurement
Systolic blood pressure was measured using the tail-cuff
method as previously described [38]. The rats were tested at 48
weeks of age, speciﬁcally undergoing 2 days of tail-cuff blood
pressure training followed by 3 days of measurements. On each
measurement day, two sets of measurement including up to ﬁve
individual measurements were obtained. Animals were tested at
approximately the same time daily, and their blood pressure was
measured in the same order.
Isolation, expansion, and characterization of bone marrow
mesenchymal stem cells
MSCs were obtained from the femora and tibiae of 12-, 24-, and
48-week-old WKY and SHRSP rats (n ¼ 6 each lineage) as
described in [39]. Brieﬂy, after animal euthanasia, the epiphyses
were removed and the bone marrow was ﬂushed into a culture
dish using Dulbecco’s minimal essential medium (DMEM; Gibco)
containing 10% fetal bovine serum (Gibco), 1% glutamine (Sigma–
Aldrich), and 1% penicillin/streptomycin (Gibco) into a culture
dish. The cells were disaggregated by gentle pipetting several
times and centrifuged for 5 min at 700 g. The supernatant was
discarded, and the cell pellet was resuspended in medium. The
bone marrow material was centrifuged through a density gradient
(1.077 g/ml Ficoll–Paque Plus, Sigma–Aldrich) (1:1) for 30 min at
1000 g to eliminate unwanted cell types that were present in the
marrow aspirate. The cells isolated from the density interface
(estimated as approximately 0.001–0.01%) were diluted to
approximately 10 ml with medium, plated in 25-cm2 plastic ﬂasks,
and kept at 37 1C in a humidiﬁed atmosphere containing 5% CO2.
At day 4, the cultures were washed with PBS (Gibco) to remove the
hematopoietic and nonadherent cells. The cells were further
expanded until they reached 80% conﬂuence, at which point they
were harvested and cultured in 75-cm2 ﬂasks. The culture medium
was changed every 3 days. To check the properties of MSCs, the
cells were grown under favorable conditions for adipogenic and
osteogenic differentiation according to the method of Pittenger
et al. [6].
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Flow cytometry
Bone marrow-derived stem cells were characterized for the
presence of mesenchymal surface antigens (CD90 and CD105) and
the absence of hematopoietic markers (CD45, c-kit, and Sca1)
before the various experiments. Antibodies against CD45, c-kit,
Sca1, CD105, and CD90 (Molecular Probes) conjugated to R-
phycoerythrin or APC (allophycocyanin) were used. Cells at the
third passage at 780% conﬂuence were enzymatically detached
by trypsinization (0.1% trypsin/EDTA; Gibco) for 5 min at 37 1C and
ﬁxed in 4% paraformaldehyde for 30 min, permeabilized with 0.1%
Triton X-100 (Gibco), and incubated with one of the conjugated
antibodies overnight. Cell sorting and analysis were performed
with a FACSCalibur ﬂow cytometry system (Becton–Dickinson
Biosciences, Franklin Lakes, NJ, USA) and CellQuest software
(Becton–Dickinson). The results were analyzed using the software
Windows Multiple Document Interface Flow Cytometry Application
(WinMDI version 2.9; Microsoft, Redmond, WA, USA).
MTT (3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide)
assay
Cell viability by MTT (Sigma–Aldrich) assay was performed to
evaluate WKY and SHRSP cells for autologous transplant (n ¼
6 each lineage and age). MSCs were plated in 96-well plates at a
density of 2104 cells/cm2. At day 14, the medium was removed,
and 90 μl of MTT solution (5 mg/ml in DMEM; Sigma–Aldrich) and
70 μl medium were added to the cell monolayers in each well.
After incubation for 2 h at 37 1C, the MTT solution was aspirated,
and the formed formazan crystals were dissolved by the addition
of 70 μl of sodium dodecyl sulfate, 10% HCl to each well. The plate
was kept in a humidiﬁed 5% CO2 incubator at 37 1C for an
additional 18 h. For the spectrophotometric quantiﬁcation, the
optical density was read at 550 nm on an ELISA plate reader
(LabSystems Multiskan MS, Helsinki, Finland). The data for the
SHRSP cells are reported as absorbance values measured in parallel
with the control cells (12-week-old WKY), over three independent
experiments, with each carried out in triplicate.
Reverse transcription–polymerase chain reaction (RT-PCR)
The expression of pro- and antiapoptotic genes was assayed by
conventional or real-time (quantitative) RT-PCR. β-Actin was used
as a housekeeping gene. Total RNA was isolated from MSCs (from
12-, 24-, and 48-week-old rats of both lineages) and hippocampal
brain tissue (from 12-, 24-, and 48-week-old rats of both lineages)
using TRIzol reagent (Invitrogen) and then treated with DNase
(Promega) to decrease the likelihood of DNA contamination.
Single-stranded cDNA was synthesized using an M-MLV reverse
transcriptase kit (Promega) and oligo(dT) primers (Promega). For
nonquantitative RT-PCR, the resultant cDNA was ampliﬁed with a
PCR Master Mix kit (Promega) for 35 cycles under the following
conditions: 5 min of incubation at 94 1C, 30 s of denaturation at
94 1C, 30 s of annealing at the primer-speciﬁc temperature, and
40 s of extension at 72 1C, followed by a 7-min ﬁnal extension step
at 72 1C. For qRT-PCR, the cDNA samples were ampliﬁed using a
Step-One-Plus real-time PCR system (Applied Biosystems) and the
SYBR Green PCR Master Mix (Applied Biosystems) according to the
manufacturer’s instructions. After ampliﬁcation, the PCR products
were analyzed with the ABI Prism sequence detection software
(Applied Biosystems). In addition, melting-curve analysis was
performed to conﬁrm the authenticity of the PCR products.
Quantitative gene expression was analyzed by the comparative
CT method (2ΔΔCT) according Livak and Schmittgen [40]. After
electrophoresis, the PCR products were visualized using ethidium
bromide staining. The image densities of the PCR products were
captured using a video-documentation system (VDS; Pharmacia)
with Liscap software. Primer sequences were designed using
Primer3 software (version 0.4.0) and are described in Table 1.
Carboxyﬂuorescein diacetate succinimyl ester (CFSE) labeling of MSCs
for transplantation
MSCs were labeled with the tracing dye CFSE (Molecular
Probes) before transplantation into the brain. CFSE passively
diffuses into cells and is colorless and nonﬂuorescent until its
acetate group is cleaved by intracellular esterases to yield highly
ﬂuorescent, amine-reactive ﬂuorophores [41]. This probe reacts
with amine-containing residues of intracellular proteins to form
dye–protein adducts that are retained well intracellularly, facil-
itating the tracking and quantiﬁcation of transplanted cells. This
dye remains visible within the cells after ﬁxation, parafﬁn-embed-
ding, and serial sectioning. The experiments were performed with
CFSE because this dye proved to be the most intense, long-lived
marker [42,42]. Brieﬂy, after 15 min of incubation with CFSE
(in PBS at a ﬁnal concentration of 20 mM) at 37 1C, the cells were
washed twice in 10 ml of PBS and then incubated in 10 ml of
DMEM for 30 min to ensure that the unbound CFSE diffused out of
the cells completely to prevent subsequent dye leakage into cells
adjacent to transplanted ﬂuorescent MSCs. Cells labeled with CFSE
can be visualized in vitro and in vivo using ﬂuorescence micro-
scopy as with ﬂuorescein isothiocyanate, using a 488-nm excita-
tion source.
Surgical procedure for cell transplantation
For MSC transplantation, the 48-week-old SHRSP rats were
anesthetized with an intraperitoneal injection of sodium thiopen-
tal (60 mg/kg). The skin on the back around the site of injection
was shaved, wiped with alcohol, and allowed to dry. In total,
1106 MSCs at passage 3 that were previously labeled with CFSE
were suspended in 10 μl PBS and injected into the cisterna magna
through the atlanto-occipital membrane in the experimental
group (group III). Alternatively, sham animals underwent identical
procedures except that only vehicle was injected into the cisterna
magna (group II—PBS). There were no obvious behavioral sequelae
(e.g., locomotor, feeding, or drinking).
Table 1
Sequences of PCR primers, product sizes, and annealing temperatures.
Gene GenBank accession number (gi) Forward and reverse sequences (5'–3') Product size (bp) Annealing temperature
β-Actin NM_031144 Fw: AACCCTAAGGCCAACCGTGAA 181 59 1C
Rv: GCGCGTAACCCTCATAGATG
Bax U49729 Fw: TGCAGAGGATGATTGCTGAC 332 60 1C
Rv: GGTGAGCGAGGCGGTGAGGAC
Bcl-2 NM_016993 Fw: CACCCCTGGCATCTTCTCCT 249 60 1C
Rv: GTTGACGCTCCCCACACACA
Fw, forward; Rv, reverse.
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Identiﬁcation of transplanted MSCs and tissue processing
The animals were sacriﬁced at 30 days after the transplantation
procedure. To observe the transplanted MSCs, the animals were
anesthetized with sodium thiopental (60 mg/kg, intraperitoneal).
The animals were, then, transcardially perfused with 0.1 M PBS
(pH 7.4) followed by 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4). The brains were removed and postﬁxed in the
same ﬁxative for 24 h. The brain tissues were cryoprotected by
inﬁltration with 30% sucrose solution overnight. Thereafter, frozen
tissues were embedded in Tissue-Tech OCT compound (Dako,
Carpinteria, CA, USA) and serially sectioned into 40-mm coronal
sections using a cryostat microtome (Leica, Wetzlar, Germany). The
sections were then collected in six-well plates containing PBS.
After the brain sections were cleaned with a PBS solution, the
nuclei were stained with DAPI (4,6 diamidino-2-phenylindole;
Sigma). A series of high-magniﬁcation images was collected at
5-mm intervals. Several sections were stained with cresyl and used
for morphological analysis. This study was designed as a blinded
analysis.
Immunohistochemistry
After transplantation, brain sections were also subjected to
immunohistochemistry to detect the double staining of CFSE and
CD90 to conﬁrm the mesenchymal identity and nondifferentiation
of transplanted cells. Brieﬂy, processed tissues were postﬁxed in
4% paraformaldehyde for 30 min, permeabilized with 0.1% Triton
X-100, and incubated with APC-conjugated anti-CD90 (1:300;
Molecular Probes) at room temperature for 2 h in the dark.
Nonspeciﬁc binding was blocked by incubation with 10% bovine
serum albumin (BSA). To visualize cellular nuclei, the specimens
were counterstained with DAPI (Sigma–Aldrich). A negative vehi-
cle test was performed using preimmune serum rather than
primary antibody to establish the speciﬁcity of the immunostain-
ing. The slides were examined under a confocal microscope (Zeiss
Axiovert 100M; Carl Zeiss, Oberkochen, Germany). MSCs in vitro
were also subjected to staining with anti-CD90 and anti-CD105 as
part of the characterization of these cells.
Superoxide anion detection
Superoxide (O2d) was detected with the oxidative ﬂuorescent
probe DHE (dihydroethidium; Molecular Probes), which reacts
with O2d , resulting in ethidine ﬂuorescence. To remove the
differences in cellular densities, DAPI was used in all of the frozen
slices. Adult (48-week-old) male WKY and SHRSP rats (untreated
and treated) were anesthetized with sodium thiopental (60 mg/kg,
intraperitoneal) and euthanized by decapitation. The brain was
removed from each animal and immediately embedded in OCT
(Dako) to generate 40-mm-thick cryosections. The freshly frozen
brain sections were incubated in a light-protected humidiﬁed
chamber at room temperature with DHE (5 mM) for 5 min and
then counterstained with the nuclear tracer DAPI (5 mM; Sigma).
The slides were immediately analyzed with a computer-based
digitizing image system (Zeiss Axiovert 100M; Carl Zeiss) con-
nected to an LSM 510 confocal laser scanning system. Fluorescence
was detected with 510–560 nm excitation and 590 nm emission
ﬁlters. The results are expressed as the DHE/DAPI ratio according
Oudot et al. [43].
Thiobarbituric acid-reactive substances (TBARS) assay
Quantiﬁcation of by-products released as a result of lipid
oxidation was performed through the TBARS method, as pre-
viously described [22]. Initially, tissue protein concentration was
measured using the Quick Start Bradford Protein Assay (Bio-Rad
Laboratories, Hercules, CA, USA). Brain fragments were weighed
and then immersed in a solution of phosphate buffer (0.1 M, pH
7.4) at a ratio of 0.5 ml buffer per 100 mg tissue, for which the
samples were ground with the aid of a Polytron PT1200CL
(Kinematica). A homogenate of each brain sample was obtained
and was centrifuged at 3000 g for 15 min at 4 1C and the super-
natant was separated for measurement of lipid oxidation. The
tissue protein concentration dosages were made according to the
data sheet instructions and BSA was used as standard. The TBARS
assay is based on the ability of aldehydes and other compounds,
especially malondialdehyde (MDA), to form a red-colored complex
with thiobarbituric acid (Sigma–Aldrich), detectable by spectro-
photometry at 532 nm. Results were expressed as nmol MDA
formed/mg protein.
Apoptotic cell staining
Neuronal DNA damage of apoptotic cells was veriﬁed by
terminal deoxynucleotidyl transferase-mediated biotinylated-
dUTP nick-end labeling (TUNEL) staining. TUNEL assay was per-
formed using the In Situ Cell Death Detection Kit Fluorescence
(Roche Applied Science, Mannheim, Germany) as per the manu-
facturer’s instructions. Postﬁxed frozen tissue sections were rinsed
with PBS for 5 min and treated with 1% Triton X-100 in PBS for
2 min. Slides were rinsed in PBS for 5 min and then incubated for
60 min at 37 1C with 50 μl of TUNEL reaction mixture. After being
washed with PBS for 10 min, the slides with coverslips were
analyzed with a laser scanning confocal microscope (Carl Zeiss).
Cell quantiﬁcation in the hippocampus was performed in an
unbiased manner according to Jung et al. [44]. The numbers of
positive cells were counted using Axion Vision release 4.8.2 (Carl
Zeiss) by outlining the region of labeled cells at 400 magniﬁca-
tion. The mean value of three sections per slide for each group
was used.
Statistical analysis
Comparison of results was performed by one-way analysis of
variance followed by Tukey’s posttest for differences among the
groups using GraphPad Prism software version 5.0 (GraphPad
Software, La Jolla, CA, USA). The data are expressed as the mean
7 standard error of the mean (SEM). Blood pressure, heart rate,
and body weight data were subjected to Student's two-tailed
unpaired t tests. Signiﬁcance was set at p r 0.05.
Results
Blood pressure measurement
The average age of the rats across both groups during blood
pressure measurements was 48 weeks. The WKY rats’ blood
Table 2
Blood pressure, body weight, and heart rate of WKY and SHRSP rats.
WKY SHRSP
Blood pressure (mm Hg) 112.872 210.973nnn
Body weight (g) 292.9715 264.6712
Heart rate (bpm) 354.6721 413.977nn
Results are presented as means 7 SEM. n ¼ 15 for each group.
nn p o 0.05.
nnn p o 0.0001.
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pressure averaged 112.8 mm Hg with a standard deviation of
2 mm Hg. The average blood pressure of the SHRSP rats was
210.9 mm Hg with a standard deviation of 3 mm Hg. Using an
unpaired t test, the average blood pressure of the SHRSP rats was
signiﬁcantly higher than the WKY rats’ average blood pressure
(p o 0.0001; Table 2). In summary, the hypertensive phenotype of
SHRSP was conﬁrmed.
Characterization of bone marrow mesenchymal stem cells
To ensure that the MSC cultures were not contaminated with
hematopoietic cells, to check for the absence of carcinogenic
markers, and especially to select the best MSC donor between
WK and SHRSP, we performed several comparison experiments.
The MSCs (estimated at about 0.001 to 0.01% of cells isolated from
Fig. 1. Morphology of MSCs. Bone marrow MSCs exhibited ﬁbroblast-like morphology. Images were taken from cultures at (A) 7 and (B) 14 days after plating. (A) Note the
presence of two types of cells: small, round cells (hematopoietic stem cells) and long-shaped cells (MSC). Scale bar, 50 mm. (B) At this stage, the cells displayed the typical
“ﬁbroblast-like” morphology shown here. The cells did not spontaneously differentiate during culture expansion. Scale bar, 100 mm.
Fig. 2. MSC characterization. The expanded, attached, mesenchymal cells were positive for CD90 and CD105, which are markers of MSCs. In contrast, the cells were negative
for other markers of the hematopoietic lineage, including CD45, Cd11b, c-kit, and Sca-1. Several of these antibodies were used routinely to characterize the expanded
mesenchymal cell population. (A) Fluorescence-activated cell sorting of cell-surface antigen expression. (B) Confocal microscopy of the expression of the antigens. MSCs were
double stained in blue with DAPI nuclear stain (a, d, g, j, n) and c-kit (b), CD45 (e), Sca-1 (h), CD90 (l), CD105 (o). The bright red cells indicate positivity. Scale bar, 20 μm.
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the density interface) described here were characterized based on
their ability to proliferate in culture with an attached well-spread
morphology (Fig. 1) by the presence or absence of a consistent set
of protein markers on their surface and by their differentiation to
multiple mesenchymal lineages under appropriate in vitro condi-
tions. We performed ﬂuorescence-activated cell sorting (Fig. 2A)
and immunocytochemical (Fig. 2B) analyses using a battery of
markers for hematopoietic and mesenchymal stem cells. We found
that the MSCs were negative for the hematopoietic markers CD45,
c-kit, Cd11b, and Sca1, but positive for mesenchymal markers
CD90 and CD105. The cells did not differentiate spontaneously
during culture expansion, but the entire culture of expanded
mesenchymal cells appeared to progress to the desired lineage,
on the basis of phenotypic characterization and histological
analysis when cultured under conditions that were favorable for
adipogenic or osteogenic differentiation (Supplementary Fig. 1).
Viability of MSCs from normotensive and hypertensive rats
The MTT results showed that the MSCs from the SHRSP rats
were less viable than the WKY rats’ cells (Fig. 3). This result
indicates a deﬁcit in MSCs in SHRSP and for this reason we chose
the MSCs of WKY rats to perform the transplant.
Effect of hypertension on MSCs
To evaluate the rate of apoptotic gene expression, a qRT-PCR
assay was performed with MSCs from SHRSP and WKY rats of
different ages. With age, the increase in Bcl-2 became proportional
to the increase in Bax, suggesting that even under hypertensive
conditions, MSCs have an antiapoptotic capacity (Fig. 4).
MSC migration to and identiﬁcation in the hippocampus
To investigate the migration of transplanted MSCs into the brain,
we directly examined brain tissue under a confocal microscope
(Fig. 5). Abundant CFSE-labeled MSCs were observed in the hippo-
campus until 30 days after transplantation (Fig. 5, images a to i). In
contrast, no labeled cells were detected in the vehicle group (PBS)
(Fig. 5, images j to m). The cells were found more precisely in the
CA1 region of the dentate gyrus of the hippocampus. These ﬁndings
are mainly due to the fact that this area is more sensitive to injury
and neuronal death [31]. We also performed immunohistochemical
staining with CD90 to verify whether the transplanted cells still
showed MSC characteristics or had differentiated into neural cells.
These cells did not differentiate into neurons or glial cells and
showed positive staining for the MSC marker used (Fig. 6).
Effects of MSC transplantation on cell death by apoptosis
Fig. 7A presents the electrophoresis gel of RT-PCR and Fig. 7B
and C show the qRT-PCR results for each group. The expression of
each gene was normalized based on the expression of β-actin. The
higher levels of the proapoptotic gene Bax in the brains of SHRSP
rats at 6 months of age (adult) indicate the initial point of neural
death by apoptosis, and the Bcl-2 expression shows the protective
role of this gene with age in normotensive rats but not in
hypertensive rats. In the case of treated hypertensive rats, we
compared the expression of Bax and Bcl-2 at 7, 15, and 30 days
after transplantation. As there was no signiﬁcant difference
between the subgroups, we chose to join the subgroups into a
single group. No difference was observed in Bax expression.
However, an increase of almost threefold of Bcl-2 (2.61) in the
MSC-treated group suggests that these cells had neuroprotective
potential, preventing neural death by apoptosis via the regulation
of pro- and antiapoptotic gene expression. As for the Bax/Bcl-2
ratio, this parameter was signiﬁcantly declined in MSC-treated rats
(1.34) compared with untreated ones (3.15).
Fig. 3. MTT assay. Viability of MSCs from WKY and SHRSP rats. Quantiﬁcation of
formazan crystal, showing that normotensive MSCs appeared to be more viable
than hypertensive MSCs. Young WKY (12-week-old) cells were used as the basis
(control) for calculation of multiple MTT survival. MTT assays were conducted in
triplicate. Percentage of cell viability: np o 0.05; nnnp o 0.0001; n ¼ 6.
Fig. 4. Bax and Bcl-2 gene expression in bone marrow MSC cultures fromWKY and SHRSP rats of different ages. (A) Expression of Bax in MSC culture. (B) Expression of Bcl-2
in MSC culture. Despite the high expression of Bax, the Bcl-2 expression also increases with age in MSCs of hypertensive rats. The results are expressed as the mean 7 SEM,
represented by error bars. nnp o 0.01; nnnp o 0.001; n ¼ 6.
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Effects of MSC transplantation on superoxide levels
Fig. 8 shows ﬂuorescence images of stained brain slices from
treated and untreated aged rats. The images clearly illustrate the
presence of superoxide in the brain of normotensive and hyper-
tensive untreated and treated rats. After MSC transplantation, the
hypertensive rats exhibited a pattern of much lower superoxide
levels, similar to normotensive rats. No differences were observed
Fig. 5. Presence of CFSE-labeled MSCs in brain of the hypertension rat model after transplant. Frozen brain sections from (a, b, and c) 7, (d, e, and f) 15, and (g, h, and i) 30
days after treatment show double staining (c, f, i, m) with the DAPI nuclear stain (b, e, h, and l) and CFSE (a, d, g, and j). Pictures of the same microscopic ﬁeld of the CA1
hippocampal subﬁeld were taken. Images j, l, and m represent the negative control stains (sham group). The bright green cells indicate transplanted MSCs labeled with CFSE
stain positivity. Scale bar, 20 mm; n ¼ 10 in each group.
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in the SHRSP untreated and PBS groups. However, markers of
superoxide anion production were nearly twice as high in the
brains of untreated SHRSP rats compared to the brains of treated
animals, which exhibited a signiﬁcant decrease in the DHE/DAPI
ratio (p o 0.05) (old WKY, 0.9070.36; old SHRSP untreated,
2.1670.86; old SHRSP sham operated, 1.9470.68; old SHRSP MSC
treated, 1.0770.52). Values were taken from sets of images of at
least 10 planes per slice.
Effects of MSC transplantation on brain morphology
In the hippocampus, cresyl staining differed between untreated
SHRSP and treated rats. Fig. 9 shows two sets of representative
images taken from 10 untreated animals compared to 10 MSC-
treated SHRSP animals. All of the untreated SHRSP rats showed
hippocampal lesions (regions close to CA1 indicated by open white
arrows) (Fig. 9A and C). In contrast, no brain lesions were noted in
WKY rats (data not shown) or MSC-treated SHRSP (Fig. 9B and D).
Black solid arrows indicate the abnormal morphological changes
noted only in untreated animals and not in the MSC-transplanted
group. These data suggest that MSCs have a neuroprotective or
regenerative capacity.
Effects of MSC transplantation on apoptosis
TUNEL staining showed apoptotic cells with typical green
nuclei. Our results conﬁrmed the notion that hypertension could
increase neuronal vulnerability [34] and cause neural death by
apoptosis. As presented in Fig. 10, the number of apoptotic cells in
MSC-treated animals was signiﬁcantly less than in the untreated
group, suggesting that MSCs could prevent neural death by
apoptosis. Furthermore, we also found that the number of labeled
cells in the MSC-treated group was similar to that in WKY animals.
Effects of MSC transplantation on lipid peroxidation
Oxidative stress can also be addressed by quantiﬁcation of
by-products released as a result of lipid oxidation, through the
TBARS method. This assay is based on the ability of aldehydes and
other compounds, especially MDA, an end product of lipid oxidation,
to form a red-colored complex with thiobarbituric acid (Sigma–
Aldrich), detectable by spectrophotometry at 532 nm. Results were
expressed as nmol MDA formed/mg protein. TBARS were found in
four times higher quantity in SHRSP than in WKY control rats
(Fig. 11). The stem cell treatment reduced lipid peroxidation in
the SHRSP brain to levels similar to those of healthy control
animals (WKY).
Fig. 6. Immunohistochemistry for CD90 in the treated groups. CD90-immunoreactive cells are not changed with time, showing that MSCs do not differentiate after
transplantation (until 30 days after transplantation). The transplanted cells showed no labeling for neural markers (data not shown). (a) CFSE, (b) CD90, (c) DAPI, (d) overlap.
Scale bar, 20 mm.
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Discussion
MSCs are attractive for cellular and clinical therapy because of
their capacity to differentiate, provide trophic support, and mod-
ulate innate immune response. Recently, several reports have
shown that MSCs have the potential to transdifferentiate into
neuronal phenotypes in vitro [7,19,21,22,45,46]. However, doubts
were raised regarding the validity of these observations. Jin et al.
[45] believed that various growth factors could drive MSCs toward
neuronal phenotypes, but morphological neuronal features and
the ectopic expression of neuronal markers are insufﬁcient indi-
cators of neuronal differentiation. In addition to morphological
studies and immunocytochemistry, it is recommended that experi-
ments on neural induction include cellular functional observa-
tions, such as the measurement of electrophysiological parameters
[7,47].
In our study, we did not attempt to observe the differentiation
of mesenchymal stem cells into neural cells, but whether and how
these cells were able to decrease superoxide, lipid peroxidation,
and neural death by apoptosis or even regenerate some areas of
the hippocampus affected by hypertension in stroke-prone spon-
taneously hypertensive rats. In this context, a similar study was
recently published and the authors showed the neuroprotective
effects of bone marrow-derived endothelial progenitor cell trans-
plantation against cerebral ischemia/reperfusion (I/R). The model
used in this study was cerebral I/R injury established by 2 h of
middle cerebral artery occlusion followed by reperfusion for 24 h.
Thus, we consider that I/R injury is an interesting model of acute
and artiﬁcially induced brain damage, whereas the SHRSP rat
seems to be a better model of genetic predisposition to sponta-
neous brain stroke.
To ensure the quality of MSC cultures and select the best donor
MSCs between WKY and SHRSP strains we performed the experi-
ments depicted in Figs. 1–6. The isolated cultured mesenchymal
cells comprised a single phenotypic population by ﬂow cytometric
analysis of expressed surface antigens. These expanded attached
mesenchymal cells were uniformly positive for CD90 and CD105.
In contrast, the mesenchymal cells were negative for other
markers of the hematopoietic lineage, including CD45, CD11b,
Sca-1, and c-kit (Fig. 2A). Several of these antibodies were used to
routinely characterize the expanded mesenchymal cell population
[2,11]. Hematopoietic cells were never identiﬁed in the expanded
cultures. Immunoﬂuorescence microscopy evaluation showed the
same expression of these markers in MSCs (Fig. 2B).
A lesion on the central nervous system (CNS) can break the
impermeability of the blood–brain barrier, which allows the
Fig. 7. Analysis of gene expression of Bax and Bcl-2 in brain tissue of WKY and SHRSP rats at different ages, before and after MSC treatment. Gene expression patterns
predicted by RT-PCR were conﬁrmed using qRT-PCR to validate selected mRNA expression. (A) Representative ethidium bromide electrophoresis gel of RT-PCR. Increased
gene expression of Bax is seen in brain tissue of SHRSP rats, compared with normotensive control WKY rats and SHRSP animals treated with MSC. Lane bp, DNA ladder.
(B) QRT-PCR gene expression of Bax. (C) QRT-PCR gene expression of Bcl-2. Note that Bax expression increases with age, whereas Bcl-2 decreases, in hypertensive rats but not
in normotensive rats. Even though the treatment with MSCs does not decrease the expression of Bax, Bcl-2 expression was increased in treated animals. β-Actin was used as
endogenous control in both cases. The mRNA levels are displayed as fold change and the results are expressed as the mean 7 SEM, represented by error bars; np o 0.05;
nnp o 0.01; nnnp o 0.001.
M.L. Calió et al. / Free Radical Biology and Medicine 70 (2014) 141–154 149
Fig. 8. (A) Confocal microscopy. Increased superoxide in the brain isolated from stroke-prone spontaneously hypertensive rats, compared with their normotensive controls
Wistar Kyoto, as detected by DHE (red spots) and DAPI (all blue nucleus). This protocol was adapted from Oudot et al. [43]. The MSCs migrated to places of greater production
of superoxide anion. Note the colocalization of MSCs (green) and superoxide anion (red) in treated animals. Scale bar, 20 mm. (B) Quantiﬁcation and analysis of ﬁgure
pixilation. The ﬂuorescence values were plotted in arbitrary units (A.U.). Results are expressed as the mean 7 SEM, represented by error bars; nnp o 0.01; nnnp o 0.001.
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invasion of some types of cells and activation of glial cells,
triggering the secretion of mediators by those cells [47,48].
We decided to use cisterna magna application because this
method can improve the transplant of MSCs in some neurodegen-
erative diseases [49]. This application avoids some brain damage
produced by a needle or cannula, which is known to induce
expression of stem cell and inﬂammatory factors [50]. In addition,
the intrathecal injection of bone marrow stromal cells shows some
therapeutic beneﬁt without any marked adverse effect in clinical
trial [51].
MSC cultivation should provide a further understanding of this
important progenitor of multiple tissue types and the potential for
new therapeutic approaches for the restoration of ROS-damaged
or diseased tissue. The therapeutic implications of these ﬁndings
are signiﬁcant. Bone marrow is by far more accessible than neural
stem cells and has the added advantage of having inherent host
compatibility. There is also no need to screen for viral and foreign
antigens before using these cells in the host. Moreover, the use of
human bone marrow stem cells from adult donors would circum-
vent many of the ethical considerations surrounding the use of
human fetal tissue. The ability of such cells to modify the tissue
microenvironment through its trophic inﬂuence may contribute
more signiﬁcantly than their capacity for transdifferentiation in
effecting tissue repair. For this reason in our study we did not
focus on the differentiation of mesenchymal stem cells into
neurons but rather on how these cells could reduce apoptosis
after brain injury.
Despite the SHRSP mesenchymal stem cells showing a potential
protective effect in vitro, we found these cells had a minor chance
of survival after transplantation because of their low viability. So,
we decided to use cells from WKY animals for the transplant
procedure.
The analysis showed a decrease in the Bcl-2 protein expression
in aged rats (Fig. 7C), which is in agreement with the model in
which an increase in Bax/Bcl-2 ratio may be related to an
enhancement in hypertension and neuronal death. In fact, the
higher levels of the proapoptotic protein Bax in the brains
of SHRSP indicate that neuronal death by apoptosis probably
contributes to the occurrence of stroke in this animal model.
These data are also consistent with the increased oxidative stress
previously observed in SHRSP [33,52]. There are signiﬁcant differ-
ences in the expression of Bax and Bcl-2 between control,
untreated, and treated animals (Fig. 7B and C). These data indicate
that MSCs from the bone marrow have an antiapoptotic action.
Given the enhanced antiapoptotic ability of MSCs, these cells can
also play a role in increasing the survival rate of the neural cells.
The Bcl-2 levels in the mesenchymal stem cell-treated animals not
only decreased in relation to old SHRSP animals but resembled
those of the control group WKY. Although the Bax expression was
not decreased in MSC-treated animals (Fig. 7B), the increase in Bcl-
2 expression made the Bax/Bcl-2 ratio decrease.
Our study also showed that superoxide production was higher
in SHRSP than in WKY rats and that this increased production was
associated with an increase in apoptosis occurrence (Figs. 8 and
10). These ﬁndings indicate a complex relationship between
oxidative stress in the pathogenesis of hypertension and stroke
[30,34,35]. However, in the treated animals, the level of superoxide
anion was decreased, indicating that MSC could have antioxidant
potential. A quantitative analysis of the ﬂuorescence intensities
indicated that, in untreated aged animals, DHE ﬂuorescence was
signiﬁcantly higher than in control and MSC-treated animals
(Fig. 8B). This comparison showed that MSCs induced a decrease
in superoxide production in aged rats. Moreover, the level of
superoxide production was higher in SHRSP than in WKY rats,
which is very probably associated with the increase in apoptosis
occurrence. Furthermore, our data have shown that Bcl-2 expres-
sion is decreased and ROS elevated in aged hippocampus, which
argues that these factors could be linked and, when associated,
contribute to an increase in tissue susceptibility to injury and
apoptosis.
It is known that some stress conditions could increase the
vulnerability of cells in the hippocampal CA1 region [31]. With
MSC transplantation, neural death and lipid peroxidation were
signiﬁcantly reduced, being similar to those of normotensive rats,
as we can see in Figs. 10 and 11, respectively. On the other hand, in
the sham group the results did not signiﬁcantly differ compared
Fig. 9. Representative histological ﬁndings of brain tissues stained by cresyl in SHRSP untreated (a and c) and MSC-treated animals (b and d). A cerebrovascular lesion in the
hippocampus in the CA1 region of the brain was seen in untreated SHRSP, as indicated by open arrows. No cerebrovascular lesions were found in MSC-treated SHRSP rats at
the same region, as indicated by dark arrows. Scale bar, 100 mm; n ¼ 10 in each group.
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with the untreated SHRSP animals. Thus we suppose that the
method we used for injection of MSCs did not increase the
oxidative stress, apoptosis, or lipid peroxidation.
Treatment of stroke is limited to an acute therapeutic inter-
vention—thrombolysis with recombinant tissue plasminogen-
activator inhibitor. Even among patients fortunate enough to
receive thrombolytic therapy, 60% show little or no improvement
in outcome. Severe neurological deﬁcits are evident and persist in
these patients. Neuroprotection associated with thrombolysis to
promote tissue perfusion is a worthy therapeutic target; however,
the small proportion of patients who will beneﬁt from such
therapy means that other approaches to promote recovery must
be investigated and developed. One approach is to use cellular
therapy and the current practice for restorative therapies is to use
stem cells as a means to facilitate recovery. In our study, we
evaluate whether stem cells are able to decrease neuronal death
by apoptosis and oxidative stress that could be contributing to the
occurrence of stroke in our model of hypertension, taking into
account that the establishment of a new cell therapy still requires
further studies.
The delivery of drugs and cells to the central nervous system
by the intrathecal route (cisterna magna) has been attempted.
Fig. 10. TUNEL staining in brain of rats. (A) Representative images from (a) WKY, (b) SHRSP, (c) sham-operated, and (d) MSC-treated slices. (B) TUNEL-positive cell (green)
apoptotic cell death was quantiﬁed. Positive apoptotic cells/mm2 were counted. Neuronal death by apoptosis was signiﬁcantly decreased in MSC-treated animals compared
with untreated SHRSP or control WKY rats. Results are expressed as the mean 7 SEM, represented by error bars; np o 0.01; nnnp o 0.001. Scale bar, 50 mm.
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The intrathecal application improves the transplant of MSCs in
some neurodegenerative diseases [48,49] because the application
avoids some brain damage produced by a needle or cannula, which
is known to induce some inﬂammatory factors [50]. In addition,
the cisterna magna injection of bone marrow stromal cells shows
some therapeutic beneﬁt without any relevant adverse effect in
clinical therapy [51].
Although the number of MSCs that were found in the brain is
apparently small, we believe that the action of these cells is not
only to repopulate the area of brain damage, but mainly to secrete
neurotrophic and proliferation factors that could induce or stimu-
late the recovery of the damage in our model SHRSP rats by
endogenous neural cells. In brief, the MSCs could provide trophic
support, helping promote survival, migration, and differentiation
of endogenous precursor cells [1–4,16]. Some these factors are
now widely known: basic ﬁbroblast growth factor [1], brain-
derived neurotrophic factor, nerve growth factor, and vascular
endothelial growth factor [53].
Taken together, our results indicate that the SHRSP rats used in
this study to obtain data on apoptosis and neural regeneration can
signiﬁcantly contribute to the advancement of research into the
application of stem cells and the prevention and treatment of
stroke.
Conclusions
This study analyzed some markers of oxidative stress and
apoptosis such as Bcl-2 and Bax expression. The increase in
superoxide levels and the reduction of Bcl-2 expression are
multifactorial events that may contribute to an increase in sus-
ceptibility to apoptosis and neurodegeneration in hypertensive old
rats. When transplanted into the hypertensive brain, MSCs from
the bone marrow enhance the viability of neural cells via anti-
apoptotic activity and antioxidant protection and by promoting
survival. These ﬁndings suggest that MSCs would be beneﬁcial for
preventing neural injury. These results support an antioxidant and
neuroprotective activity for MSCs. Stem cell transplantation is
promising, but the study of stem cell therapy in brain repair is
still in the initial stage. We should be cautious regarding the study
and application of this technology.
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